RHOA and melanoma: In contrast, bupivacaine which did not display inhibitory effects on melanoma cells did not affect RhoA, Rac1 and Ras activities (Fig. 3a to c), suggesting the specific inhibitory effects of ropivacaine on these small GTPases.